JP2025509566A5 - - Google Patents
Info
- Publication number
- JP2025509566A5 JP2025509566A5 JP2024554782A JP2024554782A JP2025509566A5 JP 2025509566 A5 JP2025509566 A5 JP 2025509566A5 JP 2024554782 A JP2024554782 A JP 2024554782A JP 2024554782 A JP2024554782 A JP 2024554782A JP 2025509566 A5 JP2025509566 A5 JP 2025509566A5
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- optionally
- approximately
- pharmaceutical
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263319657P | 2022-03-14 | 2022-03-14 | |
| US63/319,657 | 2022-03-14 | ||
| PCT/US2023/015112 WO2023177626A1 (en) | 2022-03-14 | 2023-03-13 | Lyophilized formulations of aav drug products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509566A JP2025509566A (ja) | 2025-04-11 |
| JP2025509566A5 true JP2025509566A5 (https=) | 2026-03-23 |
Family
ID=85979703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024554782A Pending JP2025509566A (ja) | 2022-03-14 | 2023-03-13 | Ａａｖ医薬製品の凍結乾燥製剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230293724A1 (https=) |
| EP (1) | EP4493162A1 (https=) |
| JP (1) | JP2025509566A (https=) |
| KR (1) | KR20250002229A (https=) |
| CN (1) | CN119072302A (https=) |
| AR (1) | AR128785A1 (https=) |
| AU (1) | AU2023233503A1 (https=) |
| CA (1) | CA3245651A1 (https=) |
| IL (1) | IL315322A (https=) |
| TW (1) | TW202406560A (https=) |
| WO (1) | WO2023177626A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025076729A1 (zh) * | 2023-10-11 | 2025-04-17 | 朗信启昇(苏州)生物制药有限公司 | 包含aav的药物组合物及其制备方法 |
| WO2025114524A1 (en) * | 2023-11-30 | 2025-06-05 | Uniqure Biopharma B.V. | Formulations for viral drug products |
| WO2025185606A1 (en) * | 2024-03-04 | 2025-09-12 | Nanjing Legend Biotech Co., Ltd. | Composition for cryoprotection of viral vector or vlp |
| WO2025188316A1 (en) * | 2024-03-08 | 2025-09-12 | Jaguar Gene Therapy, Llc | Aav pharmaceutical formulations and methods thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021009370A2 (pt) * | 2018-11-14 | 2021-08-17 | Regenxbio Inc. | método de tratamento da doença de batten cln2, composição farmacêutica e kit |
| SG11202107645RA (en) * | 2019-01-18 | 2021-08-30 | Voyager Therapeutics Inc | Methods and systems for producing aav particles |
| TW202332458A (zh) * | 2019-04-19 | 2023-08-16 | 美商銳進科斯生物股份有限公司 | 腺相關病毒載體調配物及方法 |
| WO2021071835A1 (en) * | 2019-10-07 | 2021-04-15 | Regenxbio Inc. | Adeno-associated virus vector pharmaceutical composition and methods |
| TW202144575A (zh) * | 2020-04-03 | 2021-12-01 | 美商拜奧馬林製藥公司 | 使用ａａｖ及治療調配物之苯酮尿症治療 |
-
2023
- 2023-03-13 WO PCT/US2023/015112 patent/WO2023177626A1/en not_active Ceased
- 2023-03-13 CA CA3245651A patent/CA3245651A1/en active Pending
- 2023-03-13 EP EP23716010.6A patent/EP4493162A1/en active Pending
- 2023-03-13 KR KR1020247034157A patent/KR20250002229A/ko active Pending
- 2023-03-13 US US18/120,762 patent/US20230293724A1/en active Pending
- 2023-03-13 IL IL315322A patent/IL315322A/en unknown
- 2023-03-13 TW TW112109096A patent/TW202406560A/zh unknown
- 2023-03-13 AU AU2023233503A patent/AU2023233503A1/en active Pending
- 2023-03-13 CN CN202380035210.1A patent/CN119072302A/zh active Pending
- 2023-03-13 JP JP2024554782A patent/JP2025509566A/ja active Pending
- 2023-03-14 AR ARP230100629A patent/AR128785A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025509566A5 (https=) | ||
| JP7630443B2 (ja) | アデノ随伴ウイルスベクター製剤及び方法 | |
| JP2022529002A5 (https=) | ||
| JP2021532071A5 (https=) | ||
| CN116096431A (zh) | 肽修饰的aav衣壳 | |
| CN102202688B (zh) | 稳定、干燥的轮状病毒疫苗、其组合物和制备其的方法 | |
| JP2025128087A5 (https=) | ||
| JP2020505936A5 (https=) | ||
| JP2022513034A5 (https=) | ||
| JP2022523679A5 (https=) | ||
| US20230293724A1 (en) | Lyophilized Formulations of AAV Drug Products | |
| JP2025537601A (ja) | 組換えアデノ随伴ウイルスベクターの薬学的組成物及びその適用 | |
| JP2023536883A5 (https=) | ||
| Bennett et al. | AAV6 K531 serves a dual function in selective receptor and antibody ADK6 recognition | |
| US20250213722A1 (en) | Adeno-associated virus vectors for nucleic acid delivery to retinal ganglion cells and/or retinal pigment epithelium cells | |
| US20220265853A1 (en) | Adeno-associated virus virion for gene transfer to human liver | |
| US20210017542A1 (en) | Aav6 variants | |
| JP2023544165A5 (https=) | ||
| US20250222135A1 (en) | Adeno-associated virus vectors for nucleic acid delivery across retinal regions | |
| CN112218880A (zh) | 逃避中和的肝趋向性重组aav6载体 | |
| CN119213136A (zh) | 用于将核酸递送至视网膜细胞的腺相关病毒载体 | |
| HK40111097A (zh) | 无包膜病毒的药物组合物 | |
| EP4328313A1 (en) | Adeno-associated virus virion for treating ornithine transcarbamylase deficiency | |
| HK40044939A (en) | Liver tropic recombinant aav6 vectors that evade neutralization | |
| RU2025139063A (ru) | Препараты аденоассоциированных вирусов |